Evidence map›Paper›PMID 30833423›Full record

ArticleAntimicrobial agents and chemotherapy2019

E Literacka, R Izdebski, A Baraniak, D Żabicka, A Schneider, P Urbanowicz, M Herda, W Hryniewicz, M Gniadkowski

Open access · bronzeAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

E LiterackaDepartment of Epidemiology and Clinical Microbiology, National Medicines Institute, Warsaw, Poland e.literacka@nil.gov.pl.
R IzdebskiDepartment of Molecular Microbiology, National Medicines Institute, Warsaw, Poland.
A BaraniakDepartment of Molecular Microbiology, National Medicines Institute, Warsaw, Poland.
D ŻabickaDepartment of Epidemiology and Clinical Microbiology, National Medicines Institute, Warsaw, Poland.
A SchneiderMicrobiological Laboratory, University Hospital of the Lord's Transfiguration, Poznań, Poland.
P UrbanowiczDepartment of Molecular Microbiology, National Medicines Institute, Warsaw, Poland.
M HerdaDepartment of Epidemiology and Clinical Microbiology, National Medicines Institute, Warsaw, Poland.
W HryniewiczDepartment of Epidemiology and Clinical Microbiology, National Medicines Institute, Warsaw, Poland.
M GniadkowskiDepartment of Molecular Microbiology, National Medicines Institute, Warsaw, Poland.
Narodowy Instytut Leków · PLUniversity Hospital of Lord’s Transfiguration · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bacterial Proteinsbeta-LactamasesCarbapenemsPlasmidsPolandProteus mirabilisBacterial Proteinsbeta-LactamasescarbapenemaseCarbapenemscarbapenemaseclass D carbapenemaseEnterobacteralesOXA-58Proteus mirabilis

Identifiers

PMID30833423
PMCPMC6496089
OpenAlexW2920565156

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.